Gardant Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Gardant Pharmaceuticals Ownership

Who owns Gardant Pharmaceuticals?

Gardant Pharmaceuticals is owned by Switch Pharma. It was acquired on August 25, 2006.

Gardant Pharmaceuticals Business Overview

Where is Gardant Pharmaceuticals headquartered?

Gardant Pharmaceuticals is headquartered in New York, New York.

What sector is Gardant Pharmaceuticals in?

Gardant Pharmaceuticals is a life science company.

When was Gardant Pharmaceuticals founded?

Gardant Pharmaceuticals was founded in 2000.

Life Science M&A Summary in 2006

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2006. The largest life science acquisition in 2006 was Guidant - which was acquired by Boston Scientific for $24.6B.

Subscribe to Mergr to view all 120 acquisitions of life science companies in 2006, including 22 acquisitions by private equity firms, and 98 by strategics.

Gardant Pharmaceuticals, Inc.

712 Fifth Avenue, 19th Floor,
New York, New York 10019
United States,
(212) 897-6849

Gardant Pharmaceuticals, Inc. is a pharmaceutical company.


 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Gardant Pharmaceuticals

Life Science Companies